241 related articles for article (PubMed ID: 17557835)
21. Role of histone H2A ubiquitination in Polycomb silencing.
Wang H; Wang L; Erdjument-Bromage H; Vidal M; Tempst P; Jones RS; Zhang Y
Nature; 2004 Oct; 431(7010):873-8. PubMed ID: 15386022
[TBL] [Abstract][Full Text] [Related]
22. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
Baron BW; Anastasi J; Thirman MJ; Furukawa Y; Fears S; Kim DC; Simone F; Birkenbach M; Montag A; Sadhu A; Zeleznik-Le N; McKeithan TW
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2860-5. PubMed ID: 11854457
[TBL] [Abstract][Full Text] [Related]
23. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
Carbone R; Botrugno OA; Ronzoni S; Insinga A; Di Croce L; Pelicci PG; Minucci S
Mol Cell Biol; 2006 Feb; 26(4):1288-96. PubMed ID: 16449642
[TBL] [Abstract][Full Text] [Related]
24. PU.1 can regulate the ZNF300 promoter in APL-derived promyelocytes HL-60.
Xu JH; Wang T; Wang XG; Wu XP; Zhao ZZ; Zhu CG; Qiu HL; Xue L; Shao HJ; Guo MX; Li WX
Leuk Res; 2010 Dec; 34(12):1636-46. PubMed ID: 20471086
[TBL] [Abstract][Full Text] [Related]
25. Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex.
Gao C; Dimitrov T; Yong KJ; Tatetsu H; Jeong HW; Luo HR; Bradner JE; Tenen DG; Chai L
Blood; 2013 Feb; 121(8):1413-21. PubMed ID: 23287862
[TBL] [Abstract][Full Text] [Related]
26. Anti-proliferation effect of BMI-1 in U937 cells with siRNA.
Zhu W; Huang L; Xu X; Qian H; Xu W
Int J Mol Med; 2010 Jun; 25(6):889-95. PubMed ID: 20428793
[TBL] [Abstract][Full Text] [Related]
27. Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis.
Wiederschain D; Chen L; Johnson B; Bettano K; Jackson D; Taraszka J; Wang YK; Jones MD; Morrissey M; Deeds J; Mosher R; Fordjour P; Lengauer C; Benson JD
Mol Cell Biol; 2007 Jul; 27(13):4968-79. PubMed ID: 17452456
[TBL] [Abstract][Full Text] [Related]
28. Bmi-1-green fluorescent protein-knock-in mice reveal the dynamic regulation of bmi-1 expression in normal and leukemic hematopoietic cells.
Hosen N; Yamane T; Muijtjens M; Pham K; Clarke MF; Weissman IL
Stem Cells; 2007 Jul; 25(7):1635-44. PubMed ID: 17395774
[TBL] [Abstract][Full Text] [Related]
29. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
30. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
[TBL] [Abstract][Full Text] [Related]
31. Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells.
Warner JK; Wang JC; Takenaka K; Doulatov S; McKenzie JL; Harrington L; Dick JE
Leukemia; 2005 Oct; 19(10):1794-805. PubMed ID: 16094415
[TBL] [Abstract][Full Text] [Related]
32. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins.
Guo WJ; Datta S; Band V; Dimri GP
Mol Biol Cell; 2007 Feb; 18(2):536-46. PubMed ID: 17151361
[TBL] [Abstract][Full Text] [Related]
33. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
34. SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.
Ma Y; Cui W; Yang J; Qu J; Di C; Amin HM; Lai R; Ritz J; Krause DS; Chai L
Blood; 2006 Oct; 108(8):2726-35. PubMed ID: 16763212
[TBL] [Abstract][Full Text] [Related]
35. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.
Yanagida M; Osato M; Yamashita N; Liqun H; Jacob B; Wu F; Cao X; Nakamura T; Yokomizo T; Takahashi S; Yamamoto M; Shigesada K; Ito Y
Oncogene; 2005 Jun; 24(28):4477-85. PubMed ID: 15856017
[TBL] [Abstract][Full Text] [Related]
36. Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4.
Yang J; Aguila JR; Alipio Z; Lai R; Fink LM; Ma Y
J Hematol Oncol; 2011 Sep; 4():38. PubMed ID: 21943195
[TBL] [Abstract][Full Text] [Related]
37. SALL4 is a key regulator of survival and apoptosis in human leukemic cells.
Yang J; Chai L; Gao C; Fowles TC; Alipio Z; Dang H; Xu D; Fink LM; Ward DC; Ma Y
Blood; 2008 Aug; 112(3):805-13. PubMed ID: 18487508
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis for stem-cell self-renewal.
Krosl JK; Faubert A; Sauvageau G
Hematol J; 2004; 5 Suppl 3():S118-21. PubMed ID: 15190292
[No Abstract] [Full Text] [Related]
39. Germline Stem Cell Activity Is Sustained by SALL4-Dependent Silencing of Distinct Tumor Suppressor Genes.
Chan AL; La HM; Legrand JMD; Mäkelä JA; Eichenlaub M; De Seram M; Ramialison M; Hobbs RM
Stem Cell Reports; 2017 Sep; 9(3):956-971. PubMed ID: 28867346
[TBL] [Abstract][Full Text] [Related]
40. Sall4 controls differentiation of pluripotent cells independently of the Nucleosome Remodelling and Deacetylation (NuRD) complex.
Miller A; Ralser M; Kloet SL; Loos R; Nishinakamura R; Bertone P; Vermeulen M; Hendrich B
Development; 2016 Sep; 143(17):3074-84. PubMed ID: 27471257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
